Abivax Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Abivax SA American
ABVX Stock   117.67  6.96  6.29%   
Abivax SA's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Abivax SA's valuation are provided below:
Gross Profit
6 M
Market Capitalization
8.2 B
Enterprise Value Revenue
157.627
Revenue
6 M
Earnings Share
(3.58)
We have found one hundred twenty available fundamental signals for Abivax SA American, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Abivax SA American prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 172.9 M in 2026. Enterprise Value is likely to rise to about 174.4 M in 2026

Abivax SA Total Revenue

13.03 Million

Check Abivax SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abivax SA's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 3 M or Selling General Administrative of 39.8 M, as well as many indicators such as Price To Sales Ratio of 33.77, Dividend Yield of 0.0 or PTB Ratio of 7.67. Abivax financial statements analysis is a perfect complement when working with Abivax SA Valuation or Volatility modules.
  
Build AI portfolio with Abivax Stock
Check out the analysis of Abivax SA Correlation against competitors.

Abivax SA Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets247.8 M236 M103.6 M
Slightly volatile
Short and Long Term Debt Total117.6 M112 M32.6 M
Slightly volatile
Total Current Liabilities112.1 M106.8 M32.2 M
Slightly volatile
Total Stockholder Equity53.7 M46.7 M46.3 M
Pretty Stable
Property Plant And Equipment Net3.2 M3.1 M761.8 K
Slightly volatile
Accounts Payable52.9 M50.4 M16.5 M
Slightly volatile
Cash174.1 M165.9 M54 M
Slightly volatile
Non Current Assets Total38 M39.7 M34.7 M
Slightly volatile
Cash And Short Term Investments174.1 M165.9 M57.7 M
Slightly volatile
Net Receivables18.9 M18 M7.9 M
Slightly volatile
Good Will23 M16.6 M28.4 M
Slightly volatile
Common Stock Shares Outstanding76.1 M72.5 M23.6 M
Slightly volatile
Short Term Investments116.3 K122.4 K3.6 M
Pretty Stable
Liabilities And Stockholders Equity247.8 M236 M103.6 M
Slightly volatile
Non Current Liabilities Total86.7 M82.6 M25.3 M
Slightly volatile
Other Current Assets13 M12.4 M2.7 M
Slightly volatile
Other Stockholder Equity578.3 M550.7 M180.1 M
Slightly volatile
Total Liabilities198.8 M189.3 M57.5 M
Slightly volatile
Total Current Assets206.1 M196.3 M68.7 M
Slightly volatile
Short Term Debt52.9 M50.3 M14.8 M
Slightly volatile
Common Stock764.3 K728 K244.2 K
Slightly volatile
Other Liabilities1.3 M1.4 M1 M
Slightly volatile
Long Term Debt43.3 M60 M30.9 M
Slightly volatile
Net Invested Capital114 M155.9 M73.3 M
Slightly volatile
Property Plant And Equipment Gross4.9 M4.6 M1.1 M
Slightly volatile
Short and Long Term Debt51.7 M49.3 M22.1 M
Slightly volatile
Capital Stock764.3 K728 K265.2 K
Slightly volatile
Net Working Capital70.9 M89.5 M35.3 M
Slightly volatile
Property Plant Equipment1.9 M1.8 M604.4 K
Slightly volatile
Capital Lease Obligations2.9 M2.7 M730.2 K
Slightly volatile

Abivax SA Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.3 M1.3 M340.4 K
Slightly volatile
Interest Expense3 M4.8 M2.4 M
Slightly volatile
Selling General Administrative39.8 M37.9 M11.5 M
Slightly volatile
Total Revenue13 M12.4 M2.7 M
Slightly volatile
Other Operating Expenses221.9 M211.3 M60.3 M
Slightly volatile
Cost Of Revenue772.4 K813 K7.1 M
Pretty Stable
Total Operating Expenses221.9 M211.3 M53.3 M
Slightly volatile
Research Development176.9 M168.5 M52.3 M
Slightly volatile
Reconciled Depreciation1.3 M1.3 M337.1 K
Slightly volatile
Selling And Marketing Expenses3.7 M6.8 M1.6 M
Slightly volatile

Abivax SA Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow304.2 M289.7 M62.8 M
Slightly volatile
Capital Expenditures824.3 K739.5 K587 K
Slightly volatile
End Period Cash Flow174.1 M165.9 M57 M
Slightly volatile
Change To Operating Activities9.2 M11.1 M8.2 M
Slightly volatile
Issuance Of Capital Stock474.1 K499.1 K43.5 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio7.679.458.7889
Slightly volatile
Book Value Per Share0.70.743.004
Slightly volatile
Average Payables1 M1.2 M1.3 M
Slightly volatile
PB Ratio7.679.458.7889
Slightly volatile
Payables Turnover0.0050.00530.9689
Pretty Stable
Cash Per Share1.782.061.8627
Slightly volatile
Days Payables Outstanding75.2 K71.6 K34.7 K
Slightly volatile
Income Quality0.70.790.8074
Slightly volatile
Intangibles To Total Assets0.130.140.5998
Slightly volatile
Current Ratio4.032.113.4072
Pretty Stable
Shareholders Equity Per Share0.70.743.0639
Slightly volatile
Debt To Equity2.272.161.1326
Slightly volatile
Capex Per Share0.00870.00920.0514
Pretty Stable
Average Receivables1.9 M2.1 M2.3 M
Slightly volatile
Interest Debt Per Share1.141.591.1958
Slightly volatile
Debt To Assets0.450.430.243
Slightly volatile
Price Book Value Ratio7.679.458.7889
Slightly volatile
Days Of Payables Outstanding75.2 K71.6 K34.7 K
Slightly volatile
Ebt Per Ebit0.820.890.9975
Slightly volatile
Effective Tax Rate0.03970.04180.1425
Slightly volatile
Company Equity Multiplier2.444.552.7646
Slightly volatile
Long Term Debt To Capitalization0.260.510.2864
Slightly volatile
Total Debt To Capitalization0.670.640.3442
Slightly volatile
Debt Equity Ratio2.272.161.1326
Slightly volatile
Quick Ratio4.072.113.442
Pretty Stable
Net Income Per E B T0.710.870.8565
Slightly volatile
Cash Ratio1.031.41.295
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.141.151.0474
Slightly volatile
Price To Book Ratio7.679.458.7889
Slightly volatile
Debt Ratio0.450.430.243
Slightly volatile
Price Fair Value7.679.458.7889
Slightly volatile

Abivax SA Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap172.9 M106.2 M172.2 M
Pretty Stable
Enterprise Value174.4 M117.2 M175.3 M
Pretty Stable

Abivax Fundamental Market Drivers

About Abivax SA Financial Statements

Abivax SA investors use historical fundamental indicators, such as Abivax SA's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Abivax SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue59.8 K62.8 K
Total Revenue12.4 M13 M
Cost Of Revenue813 K772.4 K
Stock Based Compensation To Revenue 2.16  2.05 
Sales General And Administrative To Revenue 3.51  3.69 
Research And Ddevelopement To Revenue 12.22  12.83 
Capex To Revenue 0.05  0.06 
Revenue Per Share 0.15  0.16 
Ebit Per Revenue(19.76)(18.77)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Additional Tools for Abivax Stock Analysis

When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY